Pharmacies across the UK continue to provide evidence of stock shortages, with 117 cases of supply problems and incidents of patient distress reported since C+D's interactive tool was launched in August. Examples included a patient battling with Parkinson's who had to miss a day of his medication because his pharmacy had exceeded its quota

C+D is building up a dossier of evidence to present to pharmacy minister Earl Howe after he called on pharmacists to prove stock shortages were harming patients. Take advantage of our resources by October 12 and we will take your evidence to the government.

● A Boots pharmacy in Huddersfield reported that a patient was moderately harmed when manufacturers could not supply the pain relief Neurontin. ● Kalmak Chemists in London also reported moderate harm to a patient it had to turn away because it could not get hold of the hormone replacement therapy Premique Low Dose. ● Mirage Pharmacy in Birmingham was still waiting for a supply of the inhaler powder Symbicort Turbohaler when it reported the details on C+D's tool. A patient had suffered low harm as a result, it said. ● Greasby Pharmacy in Greasby, Wirral, reported two incidents on the same day – it could not get hold of Cialis for erectile dysfunction or Symbicort for asthma. Patients experienced low harm as a result, it said.

Medicines that pharmacies have reported are out of stock:

Cipralex, Genotropin GoQuick, Skinoren cream, Asacol foam enema, gabapentin, Maxitrol eye drops, azathioprine, Cialis, carvedilol, Cipralex, Gentisone HC ear drops, Pancrease HL, Questran, Tildiem LA, Bricanyl, Azilect, Caverject, co-triamterzide, Lomotil, Vesicare, sulfinpyrazone,  Scopoderm patches, Spiriva refill stock, Azopt eye drops, Prograf, sodium cromoglicate eye drops, Abilify, Pramipexole, Savlon spray, Maxalt Melt